YOUTH WITH COURAGE in December-January

/in ,

Get to know all the stories of December-January:

  • Lethicia is 29 years old, and she suffers from Congenital Hypophosphatasia, an absence or low levels of serum alkaline phosphatase.
  • Nicolas Tricot is a researcher of the Institut national de la santé et de la recherche médicale looking for therapies for the Charcot Marie Tooth disease.
  • Bruno is 13 years old, and he suffers a disease called non-progressive congenital ataxia.
  • Roberta  is 23 years old and she suffers Ataxia, a rare disease which have many different variants. 

The initiative, co-funded by the Erasmus+ Programme of the European Union, aims at the creation of a European network of European foundations, institutions, and entities in order to promote the exchange of experiences and good practices. The partners of the initiative are:

  • Fundación Isabel Gemio (Spain)
  • Federación Española de Enfermedades Neuromusculares (Spain)
  • Parent Project APS per la Ricerca sulla Distrofa Muscolare (Italy)
  • Charcot-Marie-Tooth et Neuropathies Peripheriques (France)
  • Uniamo Federazione Italiana Malattie Rare (Italy)

Ancestors of the 2.6 billion-year-old gene-editing tool CRISPR are resurrected

/in

The prestigious scientific journal Nature Microbiology has published the results of an international research project that has managed to reconstruct, for the first time, the ancestors of the well-known CRISPR-Cas system from 2.6 billion years ago and has studied its evolution over time. The results suggest that the revitalized systems not only work, but are more versatile than current versions and could have revolutionary applications.

“This scientific achievement makes it possible to have gene editing tools with properties different, much more flexible, from the current ones which opens up new paths in the manipulation of DNA and treatment of diseases such as ALS, cancer, diabetes, or even as a tool for disease diagnosis”, explains Ylenia Jabalera, project researcher at nanoGUNE.

The project, directed by the Ikerbasque researcher from CIC nanoGUNE Rául Pérez-Jiménez, includes teams from the Consejo Superior de Investigaciones Científicas, the Universidad de AlicanteCentro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), and other state and international institutions.

SOURCE: madri+d